Novo Nordisk A/S (NVO) vs Verisk Analytics, Inc. (VRSK)
A side-by-side comparison of Novo Nordisk A/S and Verisk Analytics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: NVO is classified in Healthcare; VRSK is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
NVO
Novo Nordisk A/S
$50.96HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
VRSK
Verisk Analytics, Inc.
$212.26TechnologyDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — NVO vs VRSK
growth of $100 · dividends reinvested · last 17yNVO +1017.2%VRSK +698.7%NVO compounded faster
NVO VRSK
NVO vs VRSK: by the numbers
- •NVO is the larger company ($226.46B vs $27.81B market cap).
- •NVO trades at the lower trailing earnings multiple (11.62 vs 31.46 P/E), one valuation lens rather than an overall verdict.
- •NVO converts more revenue to profit (37.14% vs 29.34% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs 1.92% CAGR).
- •NVO pays the higher dividend yield (3.63% vs 0.92%).
Metrics side by side
Valuation
| Metric | NVO | VRSK |
|---|---|---|
| P/E ratio | 11.62 | 31.46 |
| Forward P/E | N/A | 26.96 |
| P/S ratio | 4.31 | 9.01 |
| P/B ratio | 7.06 | 92.99 |
| PEG ratio | 8.16 | 3.81 |
| EV / EBITDA | 9.05 | 18.83 |
| FCF yield | 2.19% | 4.03% |
Profitability
| Metric | NVO | VRSK |
|---|---|---|
| Gross margin | 81.83% | 67.44% |
| Operating margin | 45.21% | 44.87% |
| Net margin | 37.14% | 29.34% |
| ROE | 60.74% | 293.95% |
| ROIC | 29.53% | 19.56% |
Dividends
| Metric | NVO | VRSK |
|---|---|---|
| Dividend yield | 3.63% | 0.92% |
| Payout ratio | 49.80% | 29.19% |
Growth (annualized)
| Metric | NVO | VRSK |
|---|---|---|
| Revenue CAGR (5Y) | 20.73% | 1.92% |
| EPS CAGR (5Y) | 19.59% | 8.25% |
| FCF CAGR (5Y) | -5.86% | 4.58% |
| Total return CAGR (5Y) | 4.23% | 2.75% |
Frequently asked
- Which has the lower trailing P/E, NVO or VRSK?
- NVO has the lower trailing P/E: NVO trades at 11.62 and VRSK at 31.46. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, NVO or VRSK?
- Over the past five years, NVO grew revenue faster — NVO at a 20.73% CAGR versus VRSK at 1.92%.
- Does NVO or VRSK pay a bigger dividend?
- NVO yields 3.63% and VRSK yields 0.92% based on trailing dividends and the latest price.
- Is NVO or VRSK more profitable?
- NVO runs the higher net margin — NVO at 37.14% versus VRSK at 29.34%.
- How have NVO and VRSK total returns compared?
- Over the past 10 years, NVO delivered 8.30% and VRSK delivered 9.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novo Nordisk A/S P/E ratioVerisk Analytics P/E ratioNovo Nordisk A/S dividend yieldVerisk Analytics dividend yieldNovo Nordisk A/S ROEVerisk Analytics ROENovo Nordisk A/S operating marginVerisk Analytics operating marginNovo Nordisk A/S revenue growthVerisk Analytics revenue growthNovo Nordisk A/S free cash flowVerisk Analytics free cash flow
Novo Nordisk A/S & Verisk Analytics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.